Medivolve Inc MEDVF

More good news...$$$

[GeneralWolfe]

Medivolve webinar : Confirmed 200-300mil revenue for 2022, Q4 2021 had $55 mil recievables, significant collection of recievables has occurred with expectation of a max $1.6 mil deduction for bad recievables. Q1 2022 is 'good' comparative to Q4 2021 $180 per patient at the moment. Average revenue per patient per year $1-$2k. (Cross reference to medivolve database of patients they’d have in theory over $1B in recurring revenue) Closest timeline for Telehealth is 3 months for beta test (maybe) and 6 months for commercial. David Preiner is CEO to develop a telehealth business, not to manage a bunch of testing sites. Management believes the stock is significantly undervalued, but can't do anything (considering a share buyback, not a confirmation). New hire Vincent will be handling PR from now on....$$$$$, get in while its dirt cheap...

[deepoil0808]

Problem is that NO ONE TRUSTS THEM. I will point out a few points: (a)  They never told the market that they were under regulatory review, this is material news. (b)  Imagine how disorganized the operations were when you have one (1) person processing $ 55 million in receivables and getting them rejected because they were not filled out properly.   This reaks of incompetence

[Catspajamas]

Still salty, boring and transparent! Oh... and PODA!!! Bahahawawawawa!!!!

[Abovetheflay]

I ask AGAIN, why do you waste your time posting on a stock you don't own?  You must have a motive...I am guessing it is the same old tale.  You are a paid to bash the stock.... Your speculation is at best odd and certainly not accurate.  This leads me back to my first thought...you are a paid basher.